NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 27 min ago

Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)

Mon, 2022-03-21 03:21
Funding Opportunity RFA-CA-22-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH also supports innovative technology development in U.S. small businesses through its SBIR and STTR programs. As technologies transition from academic discovery to small businesses, two common challenges arise, identifying the right team with the right expertise to take the product into a small business, and funding for early-stage technology development. This FOA seeks to address both challenges simultaneously by having two equally important goals; entrepreneurial mentoring support, and product development support.

Notice of Change in Award Information to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)

Mon, 2022-03-21 02:53
Notice NOT-TR-22-025 from the NIH Guide for Grants and Contracts

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

Fri, 2022-03-18 12:58
Funding Opportunity PAR-22-139 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types of radiation used in radionuclide-based therapeutics (e.g., radiopharmaceutical therapy) on normal tissue, tumor cells and the tumor microenvironment.

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)

Fri, 2022-03-18 12:58
Funding Opportunity PAR-22-140 from the NIH Guide for Grants and Contracts. The STRIPE program seeks to support pre-clinical research projects utilizing state-of-the-art cancer biology methods and model systems that study how radiopharmaceutical therapy (RPT) agents affect the biology of normal tissue, tumor cells and the tumor microenvironment. Ideally, proposed aims will be designed to test hypotheses on how RPT dynamically impacts cancer biology processes, which can serve as the pre-clinical basis for developing new targeting strategies and approaches. Studies supported by this PAR will ultimately inform the rationale and design of new RPT-based clinical trials.

Findings of Research Misconduct

Thu, 2022-03-17 12:44
Notice NOT-OD-22-096 from the NIH Guide for Grants and Contracts

Findings of Research Misconduct

Thu, 2022-03-17 12:42
Notice NOT-OD-22-095 from the NIH Guide for Grants and Contracts

Findings of Research Misconduct

Thu, 2022-03-17 12:40
Notice NOT-OD-22-097 from the NIH Guide for Grants and Contracts

National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50) (Clinical Trial Optional)

Thu, 2022-03-17 03:36
Funding Opportunity RFA-HD-23-011 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to announce the re-competition of the National Centers for Translational Research in Reproduction and Infertility (NCTRI). The NCTRI will be administered through the Specialized Research Center (P50) award mechanism. These centers will form a national network that facilitates and accelerates bidirectional knowledge transfer between the laboratory and clinic with the ultimate goal of improving human reproductive health through research excellence and innovation.

Findings of Research Misconduct

Thu, 2022-03-17 03:24
Notice NOT-OD-22-098 from the NIH Guide for Grants and Contracts

NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership (R25 - Clinical Trial Not Allowed)

Wed, 2022-03-16 11:12
Funding Opportunity RFA-DK-22-004 from the NIH Guide for Grants and Contracts. This R25 program encourages professional societies supporting the NIDDK mission areas to develop educational programs aimed at recruiting talented fellows and junior faculty from diverse backgrounds, including those groups underrepresented in biomedical, behavioral, clinical, and social sciences research. Professional societies should propose an educational program that includes a diversity management plan that would enhance the diversity of the organization's scientific workforce and the pool of individuals from groups historically marginalized andunderrepresented in the organization's programs and leadership.

Pages